Xin Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xin Zhou has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Dingyu Zhang
Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China
1 shared publication - Junhua Zheng
Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Kebin Cheng
Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publication Kewen Cheng
Department of Respiratory Medicine, Huashan Hospital Baoshan Branch, Fudan University, Shanghai, China (mainland)
1 shared publication- Lili Hou
Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China; Department of Respiratory and Critical Care Medicine, Jiuquan Branch of Shanghai General Hospital, Gansu, 735099, China
1 shared publication Luhong Bao
Department of Respiratory and Critical Medicine, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication
Latest Publications
- Open Access
- 3 July 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-20
The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019
Background: The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. Objective: The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. Methods: The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the prognostic nomogram was constructed to predict the overall survival of COVID-19 patients. Additionally, the scRNA-seq data of BALF and PBMCs from COVID-19 patients were downloaded to investigate the underlying mechanism of the most important prognostic indicators in lungs and peripherals, respectively. Results: In total, 304 hospitalized adult COVID-19 patients in Wuhan Jinyintan Hospital were included in the retrospective study. CEA was the only laboratory indicator with significant difference in the univariate (P < 0.001) and multivariate analysis (P = 0.020). The scRNA-seq data of BALF and PBMCs from COVID-19 patients were downloaded to investigate the underlying mechanism of CEA in lungs and peripherals, respectively. The results revealed the potential roles of CEA were significantly distributed in type II pneumocytes of BALF and developing neutrophils of PBMCs, participating in the progression of COVID-19 by regulating the cell–cell communication. Conclusion: This study identifies the prognostic roles of CEA in COVID-19 patients and implies the potential roles of CEACAM8-CEACAM6 in the progression of COVID-19 by regulating the cell–cell communication of developing neutrophils and type II pneumocyte.
- 3 July 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-20
Open AccessThe predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019
Background: The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. Objective: The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. Methods: The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the prognostic nomogram was constructed to predict the overall survival of COVID-19 patients. Additionally, the scRNA-seq data of BALF and PBMCs from COVID-19 patients were downloaded to investigate the underlying mechanism of the most important prognostic indicators in lungs and peripherals, respectively. Results: In total, 304 hospitalized adult COVID-19 patients in Wuhan Jinyintan Hospital were included in the retrospective study. CEA was the only laboratory indicator with significant difference in the univariate (P < 0.001) and multivariate analysis (P = 0.020). The scRNA-seq data of BALF and PBMCs from COVID-19 patients were downloaded to investigate the underlying mechanism of CEA in lungs and peripherals, respectively. The results revealed the potential roles of CEA were significantly distributed in type II pneumocytes of BALF and developing neutrophils of PBMCs, participating in the progression of COVID-19 by regulating the cell–cell communication. Conclusion: This study identifies the prognostic roles of CEA in COVID-19 patients and implies the potential roles of CEACAM8-CEACAM6 in the progression of COVID-19 by regulating the cell–cell communication of developing neutrophils and type II pneumocyte.
- 9 March 2021
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 15 (6) , 691-698
Prevalence and screening of specific aeroallergens in Chinese male patients with chronic obstructive pulmonary disease: A retrospective cross‐sectional observational study
Introduction Sensitization to aeroallergens was linked to severe symptoms and frequent exacerbations in chronic obstructive pulmonary disease (COPD) patients. Elevated serum total immunoglobulin E (tIgE) level is a hallmark of allergic COPD patients. Phadiatop test exhibited high sensitivity for predicting specific aeroallergens (SAs) sensitization. However, the prevalence of aeroallergens, the value of Phadiatop test, alone or combined with tIgE, for predicting aeroallergens sensitization in male COPD patients have not been explored in China. Objectives To explore the prevalence and predictors of aeroallergens in the context of COPD. Methods The predictive value of Phadiatop test for SAs sensitization in male COPD patients was analyzed via the area under receiver operating characteristic curves (AUCs). Results The top five SAs in the context of COPD were d2, mx2, i6, d1, and tx5, of which the seasonal distribution showed no significant differences. Allergic group showed higher levels of blood eosinophils, total Phadiatop IgE and tIgE than the nonallergic group (all P ≤ 0.001). The AUCs of total Phadiatop IgE and tIgE for predicting the sensitization to SAs, SAs excluding mx2 (AEM) and mx2 were ((0.921 vs. 0.879, P = 0.2522), (0.967 vs. 0.807, P = 0.0003), and (0.780 vs. 0.883, P < 0.05)) (AUCPhadiatop vs AUCtIgE), respectively. The combined application of these two parameters (model) increased the AUC of SAs, significantly higher than the single parameter used (P < 0.05 for all). Conclusion d2, mx2, i6, and d1 were the top four SAs sensitized in male COPD patients; Phadiatop test was valuable for predicting the sensitization to SAs when it was > 0.13 kAU/L.
- 9 March 2021
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 15 (6) , 691-698
Prevalence and screening of specific aeroallergens in Chinese male patients with chronic obstructive pulmonary disease: A retrospective cross‐sectional observational study
Introduction Sensitization to aeroallergens was linked to severe symptoms and frequent exacerbations in chronic obstructive pulmonary disease (COPD) patients. Elevated serum total immunoglobulin E (tIgE) level is a hallmark of allergic COPD patients. Phadiatop test exhibited high sensitivity for predicting specific aeroallergens (SAs) sensitization. However, the prevalence of aeroallergens, the value of Phadiatop test, alone or combined with tIgE, for predicting aeroallergens sensitization in male COPD patients have not been explored in China. Objectives To explore the prevalence and predictors of aeroallergens in the context of COPD. Methods The predictive value of Phadiatop test for SAs sensitization in male COPD patients was analyzed via the area under receiver operating characteristic curves (AUCs). Results The top five SAs in the context of COPD were d2, mx2, i6, d1, and tx5, of which the seasonal distribution showed no significant differences. Allergic group showed higher levels of blood eosinophils, total Phadiatop IgE and tIgE than the nonallergic group (all P ≤ 0.001). The AUCs of total Phadiatop IgE and tIgE for predicting the sensitization to SAs, SAs excluding mx2 (AEM) and mx2 were ((0.921 vs. 0.879, P = 0.2522), (0.967 vs. 0.807, P = 0.0003), and (0.780 vs. 0.883, P < 0.05)) (AUCPhadiatop vs AUCtIgE), respectively. The combined application of these two parameters (model) increased the AUC of SAs, significantly higher than the single parameter used (P < 0.05 for all). Conclusion d2, mx2, i6, and d1 were the top four SAs sensitized in male COPD patients; Phadiatop test was valuable for predicting the sensitization to SAs when it was > 0.13 kAU/L.
- Open Access
- 29 November 2019
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 36 (2) , 107-113
Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations
Increasing evidence has indicated the intimate relationship between the gastrointestinal tract and respiratory tract. The microbial ecosystem has been confirmed to share key conceptual features with gut‐lung microbiome disorder and dysregulation during chronic obstructive pulmonary disease (COPD) exacerbations. However, the dynamic changes of the gut‐lung microbiome during COPD exacerbations and its potential role in disease etiology remain poorly understood. The present study investigated the dynamic changes of gut and lung microorganisms during acute exacerbation of chronic obstructive pulmonary disease (AECOPD). A longitudinal 16S ribosomal DNA survey of the gut and lung microbiome was completed on 90 feces and sputum samples collected from 15 subjects with AECOPD at three visits, which were defined as exacerbation, seven‐day stable state. The present analysis revealed a dynamic gut‐lung microbiota, where changes appeared to be associated with exacerbation events indicative of specific exacerbation phenotypes. Antibiotic and steroid treatments appeared to have differential effects on the gut‐lung microbiome, and the microbiome was associated with disease progression, but not with severity. The abundance and diversity of the microbiome was strongly influenced by the disease progression and therapy. Using culture‐independent methods to impact the gut and lung microbiota on AECOPD may be the key to understanding the interactions between the gut and lung, highlighting its potential as a biomarker, and possibly a target for future respiratory therapeutics.
- 29 November 2019
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 36 (2) , 107-113
Open AccessDynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations
Increasing evidence has indicated the intimate relationship between the gastrointestinal tract and respiratory tract. The microbial ecosystem has been confirmed to share key conceptual features with gut‐lung microbiome disorder and dysregulation during chronic obstructive pulmonary disease (COPD) exacerbations. However, the dynamic changes of the gut‐lung microbiome during COPD exacerbations and its potential role in disease etiology remain poorly understood. The present study investigated the dynamic changes of gut and lung microorganisms during acute exacerbation of chronic obstructive pulmonary disease (AECOPD). A longitudinal 16S ribosomal DNA survey of the gut and lung microbiome was completed on 90 feces and sputum samples collected from 15 subjects with AECOPD at three visits, which were defined as exacerbation, seven‐day stable state. The present analysis revealed a dynamic gut‐lung microbiota, where changes appeared to be associated with exacerbation events indicative of specific exacerbation phenotypes. Antibiotic and steroid treatments appeared to have differential effects on the gut‐lung microbiome, and the microbiome was associated with disease progression, but not with severity. The abundance and diversity of the microbiome was strongly influenced by the disease progression and therapy. Using culture‐independent methods to impact the gut and lung microbiota on AECOPD may be the key to understanding the interactions between the gut and lung, highlighting its potential as a biomarker, and possibly a target for future respiratory therapeutics.
- Open Access
- 20 May 2016
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 22, 1694-1701
Effectiveness of Inspiratory Termination Synchrony with Automatic Cycling During Noninvasive Pressure Support Ventilation
BACKGROUND:Pressure support ventilation (PSV) is a standard method for non-invasive home ventilation. A bench study was designed to compare the effectiveness of patient-ventilator inspiratory termination synchronization with automated and conventiona...
- 20 May 2016
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 22, 1694-1701
Open AccessEffectiveness of Inspiratory Termination Synchrony with Automatic Cycling During Noninvasive Pressure Support Ventilation
BACKGROUND:Pressure support ventilation (PSV) is a standard method for non-invasive home ventilation. A bench study was designed to compare the effectiveness of patient-ventilator inspiratory termination synchronization with automated and conventiona...